Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
David Kelsen
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Procedures
Chemicals & Drugs
Activities & Behaviors
Concepts & Ideas
Sign-in to see full Profile
Network (preview)
52
Saltz, Leonard
48
Ilson, David
41
Schwartz, Gary
30
Kemeny, Nancy
27
Heelan, Robert
26
Minsky, Bruce
25
O'Reilly, Eileen
20
Shah, Manish
17
Bains, Manjit
13
Cohen, Alfred
13
Kris, Mark
11
Enker, Warren
11
Brennan, Murray
10
Gonen, Mithat
10
Klimstra, David
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of David Kelsen (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Jhawer Minaxi; Coit Daniel; Brennan Murray; Qin Li-Xuan; Gonen Mithat; Klimstra David; Tang Laura; Kelsen David P; Shah Manish A
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
American journal of clinical oncology 2009;32(4):356-62.
-
2009: Tew William P; Radovich Delia; O'Reilly Eileen; Schwartz Gary; Schrag Deborah; Saltz Leonard B; Kelsen David P; Kepler Stacey; Ilson David H
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer.
Investigational new drugs 2009;27(4):366-73.
-
2009: Ku Geoffrey Y; O'Reilly Eileen M; Saltz Leonard B; Schrag Deborah; Maki Robert G; Kelsen David P; Ilson David H
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.
Cancer investigation 2009;27(4):402-6.
-
2009: Schwartz Gary K; Winter Kathryn; Minsky Bruce D; Crane Christopher; Thomson P John; Anne Pramila; Gross Howard; Willett Christopher; Kelsen David
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1956-62.
-
2009: Power Derek G; Schattner Mark A; Gerdes Hans; Brenner Baruch; Markowitz Arnold J; Capanu Marinela; Coit Daniel G; Brennan Murray; Kelsen David P; Shah Manish A
Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer.
Journal of the American College of Surgeons 2009;208(2):173-8.
-
2009: Carvajal Richard D; Tse Archie; Shah Manish A; Lefkowitz Robert A; Gonen Mithat; Gilman-Rosen Lisa; Kortmansky Jeremy; Kelsen David P; Schwartz Gary K; O'Reilly Eileen M
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2009;9(4):404-9.
-
2008: Tse Archie N; Klimstra David S; Gonen Mithat; Shah Manish; Sheikh Tahir; Sikorski Rachel; Carvajal Richard; Mui Janet; Tipian Caroll; O'Reilly Eileen; Chung Ki; Maki Robert; Lefkowitz Robert; Brown Karen; Manova-Todorova Katia; Wu Nian; Egorin Merrill J; Kelsen David; Schwartz Gary K
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(20):6704-11.
-
2008: Ajani Jaffer A; Winter Kathryn; Komaki Ritsuko; Kelsen David P; Minsky Bruce D; Liao Zhongxing; Bradley Jeffrey; Fromm Mitchel; Hornback David; Willett Christopher G
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(28):4551-6.
-
2008: Ku Geoffrey Y; Ilson David H; Schwartz Lawrence H; Capanu Marinela; O'Reilly Eileen; Shah Manish A; Kelsen David P; Schwartz Gary K
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.
Cancer chemotherapy and pharmacology 2008;62(5):875-80.
-
2008: Kelsen David
S-1 adjuvant chemotherapy for advanced gastric cancer.
Nature clinical practice. Oncology 2008;5(7):370-1.
-
2008: Shia Jinru; Tang Laura H; Weiser Martin R; Brenner Baruch; Adsay N Volkan; Stelow Edward B; Saltz Leonard B; Qin Jing; Landmann Ron; Leonard Gregory D; Dhall Deepti; Temple Larissa; Guillem Jose G; Paty Philip B; Kelsen David; Wong W Douglas; Klimstra David S
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
The American journal of surgical pathology 2008;32(5):719-31.
-
2008: Power Derek G; Kelsen David P; Shah Manish A
The Quality of Quality-of-Life and Cost-Effectiveness Analyses.
Gastrointestinal cancer research : GCR 2008;2(2):94-5.
-
2008: Ku G Y; Minsky B D; Rusch V W; Bains M; Kelsen D P; Ilson D H
Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):533-7.
-
2008: Asmis Timothy R; Chung Ki Y; Teitcher Jerrold B; Kelsen David P; Shah Manish A
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity.
Investigational new drugs 2008;26(1):95-6.
-
2008: Duffy A; Kortmansky J; Schwartz G K; Capanu M; Puleio S; Minsky B; Saltz L; Kelsen D P; O'Reilly E M
A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(1):86-91.
-
2007: Asmis T R; Capanu M; Kelsen D P; Shah M A
Systemic chemotherapy does not increase the risk of gastrointestinal perforation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(12):2006-8.
-
2007: Mansour John C; Tang Laura; Shah Manish; Bentrem David; Klimstra David S; Gonen Mithat; Kelsen David P; Brennan Murray F; Coit Daniel G
Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
Annals of surgical oncology 2007;14(12):3412-8.
-
2007: Fornier M N; Rathkopf D; Shah M; Patil S; O'Reilly E; Tse A N; Hudis C; Lefkowitz R; Kelsen D P; Schwartz G K
Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(19):5841-6.
-
2007: Kelsen David P; Winter Katryn A; Gunderson Leonard L; Mortimer Joanne; Estes Norman C; Haller Daniel G; Ajani Jaffer A; Kocha Walter; Minsky Bruce D; Roth Jack A; Willett Christopher G;
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3719-25.
-
2007: Anderson S E; Minsky B D; Bains M; Hummer A; Kelsen D; Ilson D H
Combined modality chemoradiation in elderly oesophageal cancer patients.
British journal of cancer 2007;96(12):1823-7.
-
2007: Ilson D H; Wadleigh R G; Leichman L P; Kelsen D P
Paclitaxel given by a weekly 1-h infusion in advanced esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):898-902.
-
2007: Jhawer Minaxi; Kelsen David; Shah Manish
Incorporation of biologic therapies in the management of gastroesophageal cancers.
Gastrointestinal cancer research : GCR 2007;1(2 Suppl):S22-9.
-
2007: Brenner Baruch; Tang Laura H; Shia Jinruh; Klimstra David S; Kelsen David P
Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach.
Seminars in oncology 2007;34(1):43-50.
-
2006: Shah Manish A; Ramanathan Ramesh K; Ilson David H; Levnor Alissa; D'Adamo David; O'Reilly Eileen; Tse Archie; Trocola Robin; Schwartz Lawrence; Capanu Marinela; Schwartz Gary K; Kelsen David P
Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(33):5201-6.
-
2006: Brenner B; Shah M A; Karpeh M S; Gonen M; Brennan M F; Coit D G; Klimstra D S; Tang L H; Kelsen D P
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1404-11.
-
2006: Chung Ki-Young Y; Kelsen David
Adjuvant Therapy for Stage II Colorectal Cancer: Who and with What?
Current treatment options in gastroenterology 2006;9(3):272-80.
-
2005: Kelsen David P
Multimodality therapy of local regional esophageal cancer.
Seminars in oncology 2005;32(6 Suppl 9):S6-10.
-
2005: Tew William P; Kelsen David P; Ilson David H
Targeted therapies for esophageal cancer.
The oncologist 2005;10(8):590-601.
-
2005: Abou-Alfa Ghassan K; Rowinsky Eric K; Patt Yehuda Z; Schwartz Gary K; Kelsen David P; Sharma Sunil; Siegel Eve; Becerra Carlos R; Eckhardt S Gail; Feit Kevie; De Jager Robert; O'Reilly Eileen M
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.
American journal of clinical oncology 2005;28(4):334-9.
-
2005: Shah Manish A; Kortmansky Jeremy; Motwani Monica; Drobnjak Marija; Gonen Mithat; Yi Sandy; Weyerbacher Amanda; Cordon-Cardo Carlos; Lefkowitz Robert; Brenner Baruch; O'Reilly Eileen; Saltz Leonard; Tong William; Kelsen David P; Schwartz Gary K
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridol.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(10):3836-45.
-
2005: Shah Manish A; Ilson David; Kelsen David P
Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(11):2574-6.
-
2005: Kortmansky Jeremy; Shah Manish A; Kaubisch Andreas; Weyerbacher Amanda; Yi Sandy; Tong William; Sowers Rebecca; Gonen Mithat; O'reilly Eileen; Kemeny Nancy; Ilson David I; Saltz Leonard B; Maki Robert G; Kelsen David P; Schwartz Gary K
Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1875-84.
-
2005: Chung Ki Young; Shia Jinru; Kemeny Nancy E; Shah Manish; Schwartz Gary K; Tse Archie; Hamilton Audrey; Pan Dorothy; Schrag Deborah; Schwartz Lawrence; Klimstra David S; Fridman Daniel; Kelsen David P; Saltz Leonard B
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1803-10.
-
2005: Gollub Marc J; Lefkowitz Robert; Moskowitz Chaya S; Ilson David; Kelsen David; Felderman Howard
Pelvic CT in patients with esophageal cancer.
AJR. American journal of roentgenology 2005;184(2):487-90.
-
2004: Brenner Baruch; Tang Laura H; Klimstra David S; Kelsen David P
Small-cell carcinomas of the gastrointestinal tract: a review.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2730-9.
-
2004: Shah Manish A; Kelsen David P
Combined modality therapy of esophageal cancer: changes in the standard of care?
Annals of surgical oncology 2004;11(7):641-3.
-
2004: Brenner B; Shah M A; Gonen M; Klimstra D S; Shia J; Kelsen D P
Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases.
British journal of cancer 2004;90(9):1720-6.
-
2004: Brenner Baruch; Ilson David H; Minsky Bruce D; Bains Manjit S; Tong William; Gonen Mithat; Kelsen David P
Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):45-52.
-
2003: Ilson David H; Bains Manjit; Kelsen David P; O'Reilly Eileen; Karpeh Martin; Coit Daniel; Rusch Valerie; Gonen Mithat; Wilson Katie; Minsky Bruce D
Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2926-32.
-
2003: Anderson Sibyl E; Minsky Bruce D; Bains Manjit; Kelsen David P; Ilson David H
Combined modality therapy in esophageal cancer: the Memorial experience.
Seminars in surgical oncology 2003;21(4):228-32.
-
2003: Anderson Sibyl E; O'Reilly Eileen M; Kelsen David P; Ilson David H
Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer.
Cancer investigation 2003;21(4):512-6.
-
2002: Nash Garrett M; Saltz Leonard B; Kemeny Nancy E; Minsky Bruce; Sharma Sunil; Schwartz Gary K; Ilson David H; O'Reilly Eileen; Kelsen David P; Nathanson Daniel R; Weiser Martin; Guillem Jose G; Wong W Douglas; Cohen Alfred M; Paty Philip B
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease.
Annals of surgical oncology 2002;9(10):954-60.
-
2002: Bains Manjit S; Stojadinovic Alexander; Minsky Bruce; Rusch Valerie; Turnbull Alan; Korst Robert; Ginsberg Robert; Kelsen David P; Ilson David H
A phase II trial of preoperative combined-modality therapy for localized esophageal carcinoma: initial results.
The Journal of thoracic and cardiovascular surgery 2002;124(2):270-7.
-
2002: Sharma S; Kemeny N; Kelsen D P; Ilson D; O'Reilly E; Zaknoen S; Baum C; Statkevich P; Hollywood E; Zhu Y; Saltz L B
A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5-fluorouracil and irinotecan.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1067-71.
-
2002: Ilson David H; Minsky Bruce; Kelsen David
Irinotecan, cisplatin, and radiation in esophageal cancer.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 5):11-5.
-
2002: Shah M A; Kelsen D P
[Postoperative adjuvant chemoradiotherapy in high risk stomach carcinoma]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2002;73(4):325-30.
-
2002: Schwartz Gary K; O'Reilly Eileen; Ilson David; Saltz Leonard; Sharma Sunil; Tong William; Maslak Peter; Stoltz Maxine; Eden Larry; Perkins Pam; Endres Sandra; Barazzoul John; Spriggs David; Kelsen David
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2157-70.
-
2002: Minsky Bruce D; Pajak Thomas F; Ginsberg Robert J; Pisansky Thomas M; Martenson James; Komaki Ritsuko; Okawara Gordon; Rosenthal Seth A; Kelsen David P
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1167-74.
-
2001: Culliford A T; Brooks A D; Sharma S; Saltz L B; Schwartz G K; O'Reilly E M; Ilson D H; Kemeny N E; Kelsen D P; Guillem J G; Wong W D; Cohen A M; Paty P B
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer.
Annals of surgical oncology 2001;8(10):787-95.
-
2001: Sharma S; Kemeny N; Schwartz G K; Kelsen D; O'Reilly E; Ilson D; Coyle J; De Jager R L; Ducharme M P; Kleban S; Hollywood E; Saltz L B
Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3963-70.
-
2001: Schwartz G K; Ilson D; Saltz L; O'Reilly E; Tong W; Maslak P; Werner J; Perkins P; Stoltz M; Kelsen D
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1985-92.
-
2001: Kelsen D
Preoperative chemoradiotherapy for esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):283-5.
-
2001: O'Reilly E M; Stuart K E; Sanz-Altamira P M; Schwartz G K; Steger C M; Raeburn L; Kemeny N E; Kelsen D P; Saltz L B
A phase II study of irinotecan in patients with advanced hepatocellular carcinoma.
Cancer 2001;91(1):101-5.
-
2001: Ajani J; Ettinger D; Kelsen D P; Hudis C; Kudelka A; Langer C; Pienta K; Safran H; Vokes E E; Yung W K;
Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):88-91.
-
2001: Willett C; Ajani J; Kelsen D; Sigurdson E; Abrams R; Berkey B; Benetz M; Crane C; Gaspar L; Goodyear M D; Gunderson L; Haddock M; Hoffmann J; Janjan N; John M; Kachnic L; Krieg R; Landry J; Meropol N; Minsky B; Mitchell E; Mohiuddin M; Moulder J; Myerson R; Noyes D; Pajak T F; Raben D; Regine W; Rich T; Robertson J M; Russell A; Skibber J; Kim P;
Radiation Therapy Oncology Group. Research Plan 2002-2006. Gastrointestinal Cancer Committee.
International journal of radiation oncology, biology, physics 2001;51(3 Suppl 2):19-27.
-
2000: Kawakami K; Brabender J; Lord R V; Groshen S; Greenwald B D; Krasna M J; Yin J; Fleisher A S; Abraham J M; Beer D G; Sidransky D; Huss H T; Demeester T R; Eads C; Laird P W; Ilson D H; Kelsen D P; Harpole D; Moore M B; Danenberg K D; Danenberg P V; Meltzer S J
Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma.
Journal of the National Cancer Institute 2000;92(22):1805-11.
-
2000: Kelsen D P
Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(21 Suppl):32S-4S.
-
2000: Ilson D H; Forastiere A; Arquette M; Costa F; Heelan R; Huang Y; Kelsen D P
A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus.
Cancer journal (Sudbury, Mass.) 2000;6(5):316-23.
-
2000: Kelsen D P
Surrogate endpoints in assessment of new drugs in colorectal cancer.
Lancet 2000;356(9227):353-4.
-
2000: Kelsen D P
Multimodality therapy of esophageal cancer: an update.
Cancer journal (Sudbury, Mass.) 2000;6 Suppl 2():S177-81.
-
2000: Ajani J A; Kelsen D P; Haller D; Hargraves K; Healey D
A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma.
Cancer journal (Sudbury, Mass.) 2000;6(2):78-81.
-
2000: Hsueh C T; Chiu C F; Kelsen D P; Schwartz G K
Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.
Cancer chemotherapy and pharmacology 2000;45(5):389-96.
-
2000: Kelsen D P
Neoadjuvant therapy of squamous cell carcinoma of the esophagus.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2000;155():105-12.
-
1999: Fata F; O'Reilly E; Ilson D; Pfister D; Leffel D; Kelsen D P; Schwartz G K; Casper E S
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face.
Cancer 1999;86(10):2034-7.
-
1999: Enzinger P C; Ilson D H; Kelsen D P
Chemotherapy in esophageal cancer.
Seminars in oncology 1999;26(5 Suppl 15):12-20.
-
1999: Fata F; Ron I G; Kemeny N; O'Reilly E; Klimstra D; Kelsen D P
5-fluorouracil-induced small bowel toxicity in patients with colorectal carcinoma.
Cancer 1999;86(7):1129-34.
-
1999: Ilson D H; Saltz L; Enzinger P; Huang Y; Kornblith A; Gollub M; O'Reilly E; Schwartz G; DeGroff J; Gonzalez G; Kelsen D P
Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3270-5.
-
1999: Enzinger P C; Ilson D H; Saltz L B; Martin L K; Kelsen D P
Phase II clinical trial of 13-cis-retinoic acid and interferon-alpha-2a in patients with advanced esophageal carcinoma.
Cancer 1999;85(6):1213-7.
-
1999: Hu K; Minsky B D; Cohen A M; Kelsen D P; Guillem J G; Paty P P; Quan S H
30 Gy may be an adequate dose in patients with anal cancer treated with excisional biopsy followed by combined-modality therapy.
Journal of surgical oncology 1999;70(2):71-7.
-
1999: Minsky B D; Neuberg D; Kelsen D P; Pisansky T M; Ginsberg R J; Pajak T; Salter M; Benson A B
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus.
International journal of radiation oncology, biology, physics 1999;43(3):517-23.
-
1999: O'Reilly E M; Ilson D H; Saltz L B; Heelan R; Martin L; Kelsen D P
A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.
Cancer investigation 1999;17(3):195-200.
-
1998: Kelsen D P; Ginsberg R; Pajak T F; Sheahan D G; Gunderson L; Mortimer J; Estes N; Haller D G; Ajani J; Kocha W; Minsky B D; Roth J A
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.
The New England journal of medicine 1998;339(27):1979-84.
-
1998: Saltz L B; Spriggs D; Schaaf L J; Schwartz G K; Ilson D; Kemeny N; Kanowitz J; Steger C; Eng M; Albanese P; Semple D; Hanover C K; Elfring G L; Miller L L; Kelsen D
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(12):3858-65.
-
1998: Hsueh C T; Kelsen D; Schwartz G K
UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(9):2201-6.
-
1998: Enzinger P C; Ilson D H; Saltz L B; O'Reilly E M; Kelsen D P
Irinotecan and cisplatin in upper gastrointestinal malignancies.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):110-3.
-
1998: Ilson D H; Ajani J; Bhalla K; Forastiere A; Huang Y; Patel P; Martin L; Donegan J; Pazdur R; Reed C; Kelsen D P
Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1826-34.
-
1998: Costa F; Schwartz G; Kelsen D
Adjuvant chemotherapy in gastric adenocarcinomas.
Cancer treatment and research 1998;98():41-63.
-
1997: Kelsen D; Ginsberg R; Bains M; Cooper J; Arquette M; Forastiere A A; Ilson D
A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.
Seminars in oncology 1997;24(6 Suppl 19):S19-77-S19-81.
-
1997: Saltz L B; Schwartz G K; Ilson D H; Quan V; Kelsen D P
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer.
American journal of clinical oncology 1997;20(6):621-5.
-
1997: Saltz L B; Kemeny N E; Tong W; Harrison J; Berkery R; Kelsen D P
9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma.
Cancer 1997;80(9):1727-32.
-
1997: Karpeh M S; Kelsen D P
Combined modality therapy of gastric cancer.
Surgical oncology clinics of North America 1997;6(4):741-7.
-
1997: Ilson D H; Bains M; Ginsberg R J; Kelsen D P
Neoadjuvant therapy of esophageal cancer.
Surgical oncology clinics of North America 1997;6(4):723-40.
-
1997: Schwartz G K; Farsi K; Maslak P; Kelsen D P; Spriggs D
Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1467-72.
-
1997: Hayashi K; Metzger R; Salonga D; Danenberg K; Leichman L P; Fink U; Sendler A; Kelsen D; Schwartz G K; Groshen S; Lenz H J; Danenberg P V
High frequency of simultaneous loss of p16 and p16beta gene expression in squamous cell carcinoma of the esophagus but not in adenocarcinoma of the esophagus or stomach.
Oncogene 1997;15(12):1481-8.
-
1997: Kelsen D
Multimodality therapy for adenocarcinoma of the esophagus.
Gastroenterology clinics of North America 1997;26(3):635-45.
-
1997: Cohen A M; Kelsen D; Saltz L; Minsky B D; Nelson H; Farouk R; Gunderson L L; Michelassi F; Arenas R B; Schilsky R L; Willet C G
Adjuvant therapy for colorectal cancer.
Current problems in surgery 1997;34(8):601-76.
-
1997: Kelsen D P; Portenoy R; Thaler H; Tao Y; Brennan M
Pain as a predictor of outcome in patients with operable pancreatic carcinoma.
Surgery 1997;122(1):53-9.
-
1997: Kelsen D P
Neoadjuvant therapy of esophageal cancer.
The cancer journal from Scientific American 1997;3(3):137-9.
-
1997: Grann A; Minsky B D; Cohen A M; Saltz L; Guillem J G; Paty P B; Kelsen D P; Kemeny N; Ilson D; Bass-Loeb J
Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer.
Diseases of the colon and rectum 1997;40(5):515-22.
-
1997: Schwartz G K; Ward D; Saltz L; Casper E S; Spiess T; Mullen E; Woodworth J; Venuti R; Zervos P; Storniolo A M; Kelsen D P
A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(4):537-43.
-
1997: Kelsen D P; Martin D; O'Neil J; Schwartz G; Saltz L; Sung M T; von Borstel R; Bertino J
Phase I trial of PN401, an oral prodrug of uridine, to prevent toxicity from fluorouracil in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1511-7.
-
1997: Minsky B D; Cohen A M; Enker W E; Saltz L; Guillem J G; Paty P B; Kelsen D P; Kemeny N; Ilson D; Bass J; Conti J
Preoperative 5-FU, low-dose leucovorin, and radiation therapy for locally advanced and unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1997;37(2):289-95.
-
1997: Saltz L B; Kelsen D P
Adjuvant treatment of colorectal cancer.
Annual review of medicine 1997;48():191-202.
-
1996: Meropol N J; Pazdur R; Vincent M; Willson J K; Kelsen D P; Douglass H O
Phase II study of ZD1694 in patients with advanced gastric cancer.
American journal of clinical oncology 1996;19(6):628-30.
-
1996: Saltz L B; Kanowitz J; Kemeny N E; Schaaf L; Spriggs D; Staton B A; Berkery R; Steger C; Eng M; Dietz A; Locker P; Kelsen D P
Phase I clinical and pharmacokinetic study of irinotecan, fluorouracil, and leucovorin in patients with advanced solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(11):2959-67.
-
1996: Schwartz G K; Christman K; Saltz L; Casper E; Quan V; Bertino J; Martin D S; Colofiore J; Kelsen D
A phase I trial of a modified, dose intensive FAMTX regimen (high dose 5-fluorouracil+doxorubicin+high dose methotrexate+leucovorin) with oral uridine rescue.
Cancer 1996;78(9):1988-95.
-
1996: Ajani J A; Ilson D H; Kelsen D P
Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
Seminars in oncology 1996;23(5 Suppl 12):55-8.
-
1996: Ilson D H; Kelsen D P
Management of esophageal cancer.
Oncology (Williston Park, N.Y.) 1996;10(9):1385-96, 1401-2; discussion 1402-8.
-
1996: Kelsen D
Neoadjuvant therapy for upper gastrointestinal tract cancers.
Current opinion in oncology 1996;8(4):321-8.
-
1996: Kelsen D P
Adjuvant and neoadjuvant therapy for gastric cancer.
Seminars in oncology 1996;23(3):379-89.
-
1996: Kelsen D; Karpeh M; Schwartz G; Gerdes H; Lightdale C; Botet J; Lauers G; Klimstra D; Huang Y; Saltz L; Quan V; Brennan M
Neoadjuvant therapy of high-risk gastric cancer: a phase II trial of preoperative FAMTX and postoperative intraperitoneal fluorouracil-cisplatin plus intravenous fluorouracil.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(6):1818-28.
-
1996: Fennelly D; Kelsen D P
The role of chemotherapy in the treatment of adenocarcinoma of the pancreas.
Hepato-gastroenterology 1996;43(8):356-62.
-
1996: Minsky B D; Neuberg D; Kelsen D P; Pisansky T M; Ginsberg R; Benson A
Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):149-55.
-
1995: Kelsen D P
Adjuvant therapy of upper gastrointestinal tract cancers.
Seminars in oncology 1995;22(6):582-99.
-
1995: Ajani J A; Ilson D H; Kelsen D P
The activity of paclitaxel in gastrointestinal tumors.
Seminars in oncology 1995;22(5 Suppl 12):46-50; discussion 51-3.
-
1995: Schwartz G K; Haimovitz-Friedman A; Dhupar S K; Ehleiter D; Maslak P; Lai L; Loganzo F; Kelsen D P; Fuks Z; Albino A P
Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
Journal of the National Cancer Institute 1995;87(18):1394-9.
-
1995: Kelsen D P; Ilson D H
Chemotherapy and combined-modality therapy for esophageal cancer.
Chest 1995;107(6 Suppl):224S-232S.
-
1995: Rao P H; Mathew S; Kelsen D P; Chaganti R S
Cytogenetics of gastric and esophageal adenocarcinomas. 3q deletion as a possible primary chromosomal change.
Cancer genetics and cytogenetics 1995;81(2):139-43.
-
1995: Ajani J A; Ilson D H; Daugherty K; Kelsen D P
Paclitaxel in the treatment of carcinoma of the esophagus.
Seminars in oncology 1995;22(3 Suppl 6):35-40.
-
1995: Ilson D H; Sirott M; Saltz L; Heelan R; Huang Y; Keresztes R; Kelsen D P
A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.
Cancer 1995;75(9):2197-202.
-
1995: Divgi C R; Scott A M; Dantis L; Capitelli P; Siler K; Hilton S; Finn R D; Kemeny N; Kelsen D; Kostakoglu L
Phase I radioimmunotherapy trial with iodine-131-CC49 in metastatic colon carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):586-92.
-
1995: Kelsen D P; Portenoy R K; Thaler H T; Niedzwiecki D; Passik S D; Tao Y; Banks W; Brennan M F; Foley K M
Pain and depression in patients with newly diagnosed pancreas cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(3):748-55.
-
1995: Albino A P; Jaehne J; Altorki N; Blundell M; Urmacher C; Lauwers G; Niedzwiecki D; Kelsen D P
Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 1995;21(1):56-60.
-
1995: Nabeya Y; Loganzo F; Maslak P; Lai L; de Oliveira A R; Schwartz G K; Blundell M L; Altorki N K; Kelsen D P; Albino A P
The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.
International journal of cancer. Journal international du cancer 1995;64(1):37-46.
-
1995: Minsky B D; Cohen A M; Enker W E; Kelsen D P; Kemeny N; Frankel J
Efficacy of postoperative 5-FU, high-dose leucovorin, and sequential radiation therapy for clinically resectable rectal cancer.
Cancer investigation 1995;13(1):1-7.
-
1994: Saltz L; Murphy B; Kemeny N; Bertino J; Tong W; Keefe D; Tzy-Jun Y; Tao Y; Kelsen D; O'Brien J P
A phase I trial of intrahepatic verapamil and doxorubicin. Regional therapy to overcome multidrug resistance.
Cancer 1994;74(10):2757-64.
-
1994: Kelsen D P; Saltz L; Cohen A M; Yao T J; Enker W; Tong W; Tao Y; Bertino J R
A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
Cancer 1994;74(8):2224-33.
-
1994: Kelsen D; Ajani J; Ilson D; Daugherty K; Pazdur R
A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: preliminary report.
Seminars in oncology 1994;21(5 Suppl 8):44-8.
-
1994: Kelsen D
The use of chemotherapy in the treatment of advanced gastric and pancreas cancer.
Seminars in oncology 1994;21(4 Suppl 7):58-66.
-
1994: Ilson D H; Kelsen D P
Combined modality therapy in the treatment of esophageal cancer.
Seminars in oncology 1994;21(4):493-507.
-
1994: Kelsen D P
Esophageal cancer.
Seminars in oncology 1994;21(4):401-2.
-
1994: Saltz L; Kemeny N; Schwartz G; Kelsen D
A phase II trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors.
Cancer 1994;74(3):958-61.
-
1994: Ilson D H; Kelsen D P
Adjuvant postoperative therapy of gastrointestinal malignancies.
Oncology (Williston Park, N.Y.) 1994;8(7):75-83; discussion 83, 88-90, 95.
-
1994: Ajani J A; Ilson D H; Daugherty K; Pazdur R; Lynch P M; Kelsen D P
Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus.
Journal of the National Cancer Institute 1994;86(14):1086-91.
-
1994: Rusch V; Saltz L; Venkatraman E; Ginsberg R; McCormack P; Burt M; Markman M; Kelsen D
A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1156-63.
-
1994: Kelsen D P
The role of chemotherapy in the treatment of esophageal cancer.
Chest surgery clinics of North America 1994;4(1):173-84.
-
1994: Minsky B; Cohen A; Enker W; Kelsen D; Kemeny N; Ilson D; Guillem J; Saltz L; Frankel J; Conti J
Preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for rectal cancer.
Cancer 1994;73(2):273-80.
-
1994: Christman K; Kelsen D; Saltz L; Tarassoff P G
Phase II trial of gemcitabine in patients with advanced gastric cancer.
Cancer 1994;73(1):5-7.
-
1994: Schwartz G K; Wang H; Lampen N; Altorki N; Kelsen D; Albino A P
Defining the invasive phenotype of proximal gastric cancer cells.
Cancer 1994;73(1):22-7.
-
1994: Casper E S; Green M R; Kelsen D P; Heelan R T; Brown T D; Flombaum C D; Trochanowski B; Tarassoff P G
Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas.
Investigational new drugs 1994;12(1):29-34.
-
1993: Rao P H; Mathew S; Lauwers G; Rodriguez E; Kelsen D P; Chaganti R S
Interphase cytogenetics of gastric and esophageal adenocarcinomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1993;2(4):264-8.
-
1993: Kelsen D
Neoadjuvant therapy for gastrointestinal cancers.
Oncology (Williston Park, N.Y.) 1993;7(9):25-32; discussion 32, 35-6, 41.
-
1993: Altorki N; Schwartz G K; Blundell M; Davis B M; Kelsen D P; Albino A P
Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.
Cancer 1993;72(3):649-57.
-
1993: Saltz L; Lauwers G; Wiseberg J; Kelsen D
A phase II trial of carboplatin in patients with advanced APUD tumors.
Cancer 1993;72(2):619-22.
-
1993: Saltz L; Trochanowski B; Buckley M; Heffernan B; Niedzwiecki D; Tao Y; Kelsen D
Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors.
Cancer 1993;72(1):244-8.
-
1993: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Saltz L; Frankel J
The efficacy of preoperative 5-fluorouracil, high-dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
Cancer 1993;71(11):3486-92.
-
1993: Christman K; Saltz L; Schwartz G; Friedrich C; Kelsen D
Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?
Journal of the National Cancer Institute 1993;85(10):826-7.
-
1993: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Schwartz G; Saltz L; Dougherty J; Frankel J; Wiseberg J
Pre-operative combined 5-FU, low dose leucovorin, and sequential radiation therapy for unresectable rectal cancer.
International journal of radiation oncology, biology, physics 1993;25(5):821-7.
-
1993: Atiq O T; Kelsen D P; Shiu M H; Saltz L; Tong W; Niedzwiecki D; Trochanowski B; Lin S; Toomasi F; Brennan M
Phase II trial of postoperative adjuvant intraperitoneal cisplatin and fluorouracil and systemic fluorouracil chemotherapy in patients with resected gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):425-33.
-
1993: Schwartz G K; Jiang J; Kelsen D; Albino A P
Protein kinase C: a novel target for inhibiting gastric cancer cell invasion.
Journal of the National Cancer Institute 1993;85(5):402-7.
-
1992: Saltz L; Kelsen D
Combined-modality therapy in the treatment of local-regional esophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):793-9.
-
1992: Casper E S; Schwartz G K; Johnson B; Kelsen D P
Phase II trial of edatrexate in patients with advanced pancreatic adenocarcinoma.
Investigational new drugs 1992;10(4):313-6.
-
1992: Kelsen D; Martin D S; Colofiore J; Sawyer R; Coit D
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site.
Cancer 1992;70(7):1988-92.
-
1992: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Reichman B; Saltz L; Sigurdson E R; Frankel J
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1218-24.
-
1992: Casper E S; Schwartz G K; Kelsen D P
Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma.
Investigational new drugs 1992;10(3):205-9.
-
1992: Hudis C A; Kelsen D P
Menogaril in the treatment of malignant mesothelioma: a phase II study.
Investigational new drugs 1992;10(2):103-6.
-
1992: Rusch V W; Niedzwiecki D; Tao Y; Menendez-Botet C; Dnistrian A; Kelsen D; Saltz L; Markman M
Intrapleural cisplatin and mitomycin for malignant mesothelioma following pleurectomy: pharmacokinetic studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(6):1001-6.
-
1992: Kelsen D; Atiq O T; Saltz L; Niedzwiecki D; Ginn D; Chapman D; Heelan R; Lightdale C; Vinciguerra V; Brennan M
FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(4):541-8.
-
1992: Kelsen D; Lovett D; Wong J; Saltz L; Buckley M; Murray P; Heelan R; Lightdale C
Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(2):269-74.
-
1992: Minsky B D; Cohen A M; Kemeny N; Enker W E; Kelsen D P; Reichman B; Saltz L; Sigurdson E R; Frankel J
Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(1):79-84.
-
1992: Minsky B D; Cohen A M; Enker W E; Kelsen D P; Kemeny N; Riechman B; Saltz L; Sigurdson E R; Frankel J
Phase I trial of postoperative 5-FU, radiation therapy, and high dose leucovorin for resectable rectal cancer.
International journal of radiation oncology, biology, physics 1992;22(1):139-45.
-
1992: Markman M; Kelsen D
Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma.
Journal of cancer research and clinical oncology 1992;118(7):547-50.
-
1991: Kelsen D
Adjuvant therapy of upper gastrointestinal tract cancers.
Seminars in oncology 1991;18(6):543-59.
-
1991: Crown J; Casper E S; Botet J; Murray P; Kelsen D P
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1682-6.
-
1991: Kelsen D; Hudis C; Niedzwiecki D; Dougherty J; Casper E; Botet J; Vinciguerra V; Rosenbluth R
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma.
Cancer 1991;68(5):965-9.
-
1991: Kelsen D; Atiq O T
Therapy of upper gastrointestinal tract cancers.
Current problems in cancer 1991;15(5):235-94.
-
1991: Minsky B D; Cohen A M; Enker W E; Kelsen D; Kemeny N; Sigurdson E
Adjuvant postoperative radiation therapy for resectable rectal cancer.
Radiation medicine 1991;9(4):153-8.
-
1991: Minsky B D; Kemeny N; Cohen A M; Enker W E; Kelsen D P; Reichman B; Saltz L; Sigurdson E R; Frankel J
Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer.
Cancer 1991;67(11):2859-66.
-
1991: Lovett D; Kelsen D; Eisenberger M; Houston C
A phase II trial of carboplatin and vinblastine in the treatment of advanced squamous cell carcinoma of the esophagus.
Cancer 1991;67(2):354-6.
-
1990: Kemeny N; Younes A; Seiter K; Kelsen D; Sammarco P; Adams L; Derby S; Murray P; Houston C
Interferon alpha-2a and 5-fluorouracil for advanced colorectal carcinoma. Assessment of activity and toxicity.
Cancer 1990;66(12):2470-5.
-
1990: Houldsworth J; Cordon-Cardo C; Ladanyi M; Kelsen D P; Chaganti R S
Gene amplification in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6417-22.
-
1990: Rodriguez E; Rao P H; Ladanyi M; Altorki N; Albino A P; Kelsen D P; Jhanwar S C; Chaganti R S
11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.
Cancer research 1990;50(19):6410-6.
-
1990: Saltz L; Kelsen D
A phase I trial of cisplatin in hypertonic saline and escalating doses of 5-fluorouracil by continuous intravenous infusion in patients with advanced malignancies.
Cancer 1990;66(8):1688-91.
-
1990: Kemeny N; Childs B; Larchian W; Rosado K; Kelsen D
A phase II trial of recombinant tumor necrosis factor in patients with advanced colorectal carcinoma.
Cancer 1990;66(4):659-63.
-
1990: van Dekken H; Pizzolo J G; Kelsen D P; Melamed M R
Targeted cytogenetic analysis of gastric tumors by in situ hybridization with a set of chromosome-specific DNA probes.
Cancer 1990;66(3):491-7.
-
1990: Ginn D; Kelsen D; Eisenberger M; Heelan R; Magill G
Phase II trial of carboplatin and vinblastine in adenocarcinoma of the stomach.
Investigational new drugs 1990;8(3):321-4.
-
1990: Kelsen D P; Minsky B; Smith M; Beitler J; Niedzwiecki D; Chapman D; Bains M; Burt M; Heelan R; Hilaris B
Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1352-61.
-
1990: Nanus D M; Kelsen D P; Mentle I R; Altorki N; Albino A P
Infrequent point mutations of ras oncogenes in gastric cancers.
Gastroenterology 1990;98(4):955-60.
-
1990: Goldenberg A S; Kelsen D; Dougherty J; Magill G
Phase II study of CHIP chemotherapy in advanced adenocarcinomas of the upper gastrointestinal tract.
Investigational new drugs 1990;8(1):71-5.
-
1990: Kambhu S A; Kelsen D P; Fiore J; Niedzwiecki D; Chapman D; Vinciguerra V; Rosenbluth R
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results.
American journal of clinical oncology 1990;13(1):55-60.
-
1990: Kelsen D P; Bains M; Burt M
Neoadjuvant chemotherapy and surgery of cancer of the esophagus.
Seminars in surgical oncology 1990;6(5):268-73.
-
1990: Bajorin D; Kelsen D P
A phase I trial of combination chemotherapy employing carboplatin, vinca alkaloids, with or without bleomycin in patients with advanced malignant tumors.
Cancer investigation 1990;8(2):135-41.
-
1989: Dougherty J B; Kelsen D; Kemeny N; Magill G; Botet J; Niedzwiecki D
Advanced pancreatic cancer: a phase I-II trial of cisplatin, high-dose cytarabine, and caffeine.
Journal of the National Cancer Institute 1989;81(22):1735-8.
-
1989: Kelsen D
Neoadjuvant therapy of esophageal cancer.
Canadian journal of surgery. Journal canadien de chirurgie 1989;32(6):410-4.
-
1989: Nichols G L; Kelsen D P
Small cell carcinoma of the esophagus. The Memorial Hospital experience 1970 to 1987.
Cancer 1989;64(7):1531-3.
-
1989: Lightdale C J; Botet J F; Kelsen D P; Turnbull A D; Brennan M F
Diagnosis of recurrent upper gastrointestinal cancer at the surgical anastomosis by endoscopic ultrasound.
Gastrointestinal endoscopy 1989;35(5):407-12.
-
1989: Nanus D M; Kelsen D P; Niedzwiecki D; Chapman D; Brennan M; Cheng E; Melamed M
Flow cytometry as a predictive indicator in patients with operable gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1105-12.
-
1988: Nanus D M; Kelsen D P; Lipperman R; Eisenberger M
Phase II trial of ifosfamide in epidermoid carcinoma of the esophagus: unexpectant severe toxicity.
Investigational new drugs 1988;6(3):239-41.
-
1988: Kelsen D
Chemotherapy of gastric cancer: a review.
Israel journal of medical sciences 1988;24(9-10):557-61.
-
1988: Frame J; Kelsen D; Kemeny N; Cheng E; Niedzwiecki D; Heelan R; Lippermann R
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors.
American journal of clinical oncology 1988;11(4):490-5.
-
1988: Scher H I; Shank B; Chapman R; Geller N; Pinsky C; Gralla R; Kelsen D; Bosl G; Golbey R; Petroni G
Randomized trial of combined modality therapy with and without thymosin fraction V in the treatment of small cell lung cancer.
Cancer research 1988;48(6):1663-70.
-
1988: Reichman B; Markman M; Hakes T; Kemeny N; Kelsen D; Hoskins W; Rubin S; Lewis J L
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):158-62.
-
1988: Goldenberg A; Kelsen D; Benedetto P
Phase II trial of mitoxantrone in advanced gastric cancer.
Oncology 1988;45(4):273-5.
-
1987: Bajorin D; Kelsen D; Mintzer D M
Phase II trial of mitomycin in malignant mesothelioma.
Cancer treatment reports 1987;71(9):857-8.
-
1987: Kelsen D P
Preoperative chemotherapy in esophageal carcinoma.
World journal of surgery 1987;11(4):433-8.
-
1987: Nanus D M; Kelsen D; Clark D G
Radiation-induced angiosarcoma.
Cancer 1987;60(4):777-9.
-
1987: Kris M G; Gralla R J; Burke M T; Fiore J J; Kelsen D P; Marks L D; Heelan R T
Phase II trial of esorubicin in patients with advanced non-small cell lung cancer.
Cancer treatment reports 1987;71(7-8):783-4.
-
1987: Kris M G; Gralla R J; Burke M T; Berkowitz L D; Marks L D; Kelsen D P; Heelan R T
Phase II trial of oral piritrexim (BW301U) in patients with stage III non-small cell lung cancer.
Cancer treatment reports 1987;71(7-8):763-4.
-
1987: Kelsen D
Multimodality therapy of esophageal carcinoma: still an experimental approach.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):530-1.
-
1987: Kelsen D P; Buckner J; Einzig A; Magill G; Heelan R; Vinciguerra V
Phase II trial of cisplatin and etoposide in adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1987;71(3):329-30.
-
1987: Kelsen D; Fiore J; Heelan R; Cheng E; Magill G
Phase II trial of etoposide in APUD tumors.
Cancer treatment reports 1987;71(3):305-7.
-
1986: O'Connell J P; Kris M G; Gralla R J; Groshen S; Trust A; Fiore J J; Kelsen D P; Heelan R T; Golbey R B
Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1604-14.
-
1986: Bajorin D; Kelsen D; Heelan R
Phase II trial of dichloromethotrexate in epidermoid carcinoma of the esophagus.
Cancer treatment reports 1986;70(10):1245-6.
-
1986: Kris M G; Gralla R J; Wertheim M S; Kelsen D P; O'Connell J P; Burke M T; Fiore J J; Cibas I R; Heelan R T
Trial of the combination of mitomycin, vindesine, and cisplatin in patients with advanced non-small cell lung cancer.
Cancer treatment reports 1986;70(9):1091-6.
-
1986: Kelsen D P; Fein R; Coonley C; Heelan R; Bains M
Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
Cancer treatment reports 1986;70(2):255-9.
-
1986: Swaroop V S; Kelsen D
Chemotherapy of gastric cancer.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 1986;5(1):5-6.
-
1986: Kelsen D P; Hilaris B; Martini N
Neoadjuvant chemotherapy and surgery of cancer of the esophagus.
Seminars in surgical oncology 1986;2(3):170-6.
-
1985: Einzig A; Kelsen D P; Cheng E; Sordillo P; Heelan R; Winn R; Magill G
Phase II trial of carboplatin in patients with adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1985;69(12):1453-4.
-
1985: Fein R; Kelsen D P; Geller N; Bains M; McCormack P; Brennan M F
Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy.
Cancer 1985;56(10):2512-8.
-
1985: Sternberg C; Kelsen D; Dukeman M; Leichman L; Heelan R
Carboplatin: a new platinum analog in the treatment of epidermoid carcinoma of the esophagus.
Cancer treatment reports 1985;69(11):1305-7.
-
1985: Kris M G; Gralla R J; Clark R A; Tyson L B; Fiore J J; Kelsen D P; Groshen S
Consecutive dose-finding trials adding lorazepam to the combination of metoclopramide plus dexamethasone: improved subjective effectiveness over the combination of diphenhydramine plus metoclopramide plus dexamethasone.
Cancer treatment reports 1985;69(11):1257-62.
-
1985: Kris M G; Gralla R J; Clark R A; Tyson L B; O'Connell J P; Wertheim M S; Kelsen D P
Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(10):1379-84.
-
1985: Kris M G; Gralla R J; Kelsen D P; Casper E S; Burke M T; Fiore J J; Cibas I R; Heelan R T
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer.
American journal of clinical oncology 1985;8(5):377-9.
-
1985: Coonley C J; Schauer P; Kelsen D P; Sordillo P; Huvos A G
Chemotherapy of metastatic sweat gland carcinoma. A retrospective review.
American journal of clinical oncology 1985;8(4):307-11.
-
1985: Mintzer D M; Kelsen D; Frimmer D; Heelan R; Gralla R
Phase II trial of high-dose cisplatin in patients with malignant mesothelioma.
Cancer treatment reports 1985;69(6):711-2.
-
1985: Fiore J J; Kelsen D P; Gralla R J; Casper E S; Magill G; Cheng E; Ochoa M
Adenocarcinoma of unknown primary origin: treatment with vindesine and doxorubicin.
Cancer treatment reports 1985;69(6):591-4.
-
1985: Kris M G; Gralla R J; Kalman L A; Kelsen D P; Casper E S; Burke M T; Groshen S; Cibas I R; Bagin R; Heelan R T
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
Cancer treatment reports 1985;69(4):387-95.
-
1985: Kris M G; Gralla R J; Kelsen D P; Casper E S; Burke M T; Fiore J J; Cibas I R; Heelan R T
Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
Chest 1985;87(3):368-72.
-
1985: Kelsen D P; Alcock N; Young C W
Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations.
American journal of clinical oncology 1985;8(1):77-80.
-
1985: Kris M G; Gralla R J; Tyson L B; Clark R A; Kelsen D P; Reilly L K; Groshen S; Bosl G J; Kalman L A
Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patients.
Cancer 1985;55(3):527-34.
-
1985: Kelsen D
Chemotherapy of esophageal cancer.
European journal of cancer & clinical oncology 1985;21(1):5-7.
-
1985: Einzig A I; Gralla R J; Leyland-Jones B R; Kelsen D P; Cibas I; Lewis E; Greenberg E
Phase I study of elliptinium (2-N-methyl-9-hydroxyellipticinium).
Cancer investigation 1985;3(3):235-41.
-
1985: Kelsen D
Chemotherapy-based multi-modality therapy of esophageal cancer.
Progress in clinical and biological research 1985;201():241-52.
-
1984: Coonley C J; Bains M; Hilaris B; Chapman R; Kelsen D P
Cisplatin and bleomycin in the treatment of esophageal carcinoma. A final report.
Cancer 1984;54(11):2351-5.
-
1984: Einzig A; Kelsen D; Cheng E; Sordillo P; Raymond V; Magill G
Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract.
Cancer treatment reports 1984;68(11):1415-6.
-
1984: Zeffren J; Yagoda A; Kelsen D; Winn R
Phase I-II trial of a 5-day continuous infusion of vinblastine sulfate.
Anticancer research 1984;4(6):411-3.
-
1984: Kelsen D; Bains M; Hilaris B; Martini N
Combined-modality therapy of esophageal cancer.
Seminars in oncology 1984;11(2):169-77.
-
1984: Kelsen D
Chemotherapy of esophageal cancer.
Seminars in oncology 1984;11(2):159-68.
-
1984: Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Cancer treatment reports 1984;68(3):561-2.
-
1984: Gralla R J; Tyson L B; Bordin L A; Clark R A; Kelsen D P; Kris M G; Kalman L B; Groshen S
Antiemetic therapy: a review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol.
Cancer treatment reports 1984;68(1):163-72.
-
1984: Scher H I; Kelsen D; Kalman L; Jones L; Burchenal J; Gralla R
Phase-II trial of 1,2-diaminocyclohexane (4-carboxyphthalato) platinum (II) (DACCP) in non-small cell lung cancer.
Cancer chemotherapy and pharmacology 1984;12(2):101-3.
-
1983: Kelsen D; Hilaris B; Coonley C; Chapman R; Lesser M; Dukeman M; Heelan R; Bains M
Cisplatin, vindesine, and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma.
The American journal of medicine 1983;75(4):645-52.
-
1983: Kelsen D P; Heelan R; Coonley C; Bains M; Martini N; Hilaris B; Golbey R B
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma.
American journal of clinical oncology 1983;6(5):539-46.
-
1983: Kalman L A; Stoopler M B; Casper E S; Kelsen D P; Kris M G; Gralla R J
Phase II trial of PCNU in non-small cell lung cancer.
Cancer treatment reports 1983;67(9):837.
-
1983: Kelsen D; Gralla R; Cheng E; Martini N
Vindesine in the treatment of malignant mesothelioma: a phase II study.
Cancer treatment reports 1983;67(9):821-2.
-
1983: Kalman L A; Kris M G; Gralla R J; Kelsen D P; Casper E S; Heelan R T; Wittes R E
Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer.
Cancer treatment reports 1983;67(6):591-2.
-
1983: Kelsen D P; Magill G B; Cheng E; Dukeman M; Sordillo P; Heelan R; Yagoda A
Phase II trial of etoposide in adenocarcinomas of the upper gastrointestinal tract.
Cancer treatment reports 1983;67(5):509-10.
-
1983: Coonley C J; Bains M; Heelan R; Dukeman M; Kelsen D P
Phase II study of etoposide in the treatment of esophageal carcinoma.
Cancer treatment reports 1983;67(4):397-8.
-
1983: Casper E S; Kelsen D P; Alcock N W; Lewis J L
Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
Cancer treatment reports 1983;67(3):235-8.
-
1983: Itri L M; Gralla R J; Kelsen D P; Chapman R A; Casper E S; Braun D W; Howard J E; Golbey R; Heelan R T
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
Cancer 1983;51(6):1050-5.
-
1982: Natale R B; Yagoda A; Kelsen D P; Gralla R J; Watson R C
Phase II trial of PALA in hypernephroma and urinary bladder cancer.
Cancer treatment reports 1982;66(12):2091-2.
-
1982: Kelsen D
Treatment of advanced esophageal cancer.
Cancer 1982;50(11 Suppl):2576-81.
-
1982: Kelsen D P; Scher H; Alcock N; Leyland-Jones B; Donner A; Williams L; Greene G; Burchenal J H; Tan C; Philips F S; Young C W
Phase I clinical trial and pharmacokinetics of 4'-carboxyphthalato(1,2-diaminocyclohexane)platinum(II).
Cancer research 1982;42(11):4831-5.
-
1982: Bains M S; Kelsen D P; Beattie E J; Martini N
Treatment of esophageal carcinoma combined preoperative chemotherapy.
The Annals of thoracic surgery 1982;34(5):521-8.
-
1982: Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Cancer treatment reports 1982;66(6):1427-9.
-
1982: Sordillo P P; Magill G B; Gralla R J; Kelsen D P
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
American journal of clinical oncology 1982;5(3):273-5.
-
1982: Kelsen D P; Hoffman J; Alcock N; Cheng E; Bailey E; Young C; Golbey R; Fortner J
Pharmacokinetics of cisplatin regional hepatic infusions.
American journal of clinical oncology 1982;5(2):173-8.
-
1982: Kelsen D P; Yagoda A; Warrell R; Chapman R; Whittes R; Gralla R J; Casper E; Young C W
Phase II trials of methylglyoxal-bis (guanylhydrazone).
American journal of clinical oncology 1982;5(2):221-5.
-
1982: Kelsen D P; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
Cancer 1982;49(6):1174-7.
-
1982: Itri L M; Gralla R J; Chapman R A; Kelsen D P; Casper E S; Golbey R B
Phase II trial of VP-16-213 in non-small-cell lung cancer.
American journal of clinical oncology 1982;5(1):45-7.
-
1982: Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Cancer treatment reports 1982;66(2):247-51.
-
1982: Chapman R; Itri L; Gralla R; Kelsen D; Casper E; Golbey R
Phase II trial of VP16-213 in non-small cell lung cancer (NSCLC).
Cancer chemotherapy and pharmacology 1982;7(2-3):205-7.
-
1981: Gralla R J; Casper E S; Kelsen D P; Braun D W; Dukeman M E; Martini N; Young C W; Golbey R B
Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.
Annals of internal medicine 1981;95(4):414-20.
-
1981: Gralla R J; Itri L M; Pisko S E; Squillante A E; Kelsen D P; Braun D W; Bordin L A; Braun T J; Young C W
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
The New England journal of medicine 1981;305(16):905-9.
-
1981: Gralla R J; Wittes R E; Casper E S; Kelsen D P; Cvitkovic E; Magill G B; Krown S E; Golbey R B
Chemotherapy of non-small cell lung cancer: clinical trials at the Memorial Sloan-Kettering Cancer Center.
World journal of surgery 1981;5(5):667-73.
-
1981: Kelsen D P; Bains M; Chapman R; Golbey R
Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
Cancer treatment reports 1981;65(9-10):781-5.
-
1981: Kelsen D P; Ahuja R; Hopfan S; Bains M S; Kosloff C; Martini N; McCormack P; Golbey R B
Combined modality therapy of esophageal carcinoma.
Cancer 1981;48(1):31-7.
-
1981: Casper E S; Gralla R J; Lynch G R; Jones B R; Woodcock T M; Gordon C; Kelsen D P; Young C W
Phase I and pharmacological studies of pentamethylmelamine administered by 24-hour intravenous infusion.
Cancer research 1981;41(4):1402-6.
-
1981: Kelsen D P; Ribaud P; Alcock N; Burchenal J H; Young C W; Mathe G
Pharmacokinetics of Malonato (1,2 diaminocyclohexane) platinum.
Cancer clinical trials 1981;4(4):429-31.
-
1981: Lynch G R; Gralla R J; Kelsen D P; Casper E S; Stoopler M B; Golbey R B
Phase II evaluation of metoprine in patients with non-small-cell lung carcinoma.
Cancer clinical trials 1981;4(3):273-6.
-
1981: Chapman R; Kelsen D; Gralla R; Itri L; Casper E; Young C; Golbey R
Phase II trial of methylglyoxal-bis-(guanylhydrazone) in non-small-cell lung cancer.
Cancer clinical trials 1981;4(4):389-91.
-
1981: Kelsen D P
Advances in chemotherapy of esophageal cancer.
Clinical bulletin 1981;11(3):131-8.
-
1980: Kelsen D P; Alcock N; Yeh S; Brown J; Young C
Pharmacokinetics of gallium nitrate in man.
Cancer 1980;46(9):2009-13.
-
1980: Kelsen D P; Weston E; Kurtz R; Cvitkovic E; Lieberman P; Golbey R B
Small-cell carcinoma of the esophagus: treatment by chemotherapy alone.
Cancer 1980;45(7):1558-61.
-
1980: Casper E S; Gralla R J; Kelsen D P; Houghton A; Golbey R B; Young C W
Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in patients with non-small cell carcinoma of the lung.
Cancer treatment reports 1980;64(4-5):705-7.
-
1980: Casper E S; Gralla R J; Kelsen D P; Natale R B; Sordillo P; Houghton A
Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Cancer treatment reports 1980;64(2-3):345-7.
-
1980: Ribaud P; Kelsen D P; Alcock N; Garcia-Giralt E; Dubouch P; Young C C; Muggia F M; Burchenal J H; Mathé G
Preclinical and phase I studies of malonatoplatinum.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1980;74():156-62.
-
1979: Casper E S; Gralla R J; Kelsen D P; Cvitkovic E; Golbey R B
Phase II study of high-dose cis-dichlorodiammineplatinum(II) in the treatment of non-small cell lung cancer.
Cancer treatment reports 1979;63(11-12):2107-9.
-
1979: Casper E S; Kelsen D P; Alcock N W; Young C W
Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II).
Cancer treatment reports 1979;63(11-12):2023-5.
-
1979: Kelsen D P; Bains M; Cvitkovic E; Golbey R
Vindesine in the treatment of esophageal carcinoma: a phase II study.
Cancer treatment reports 1979;63(11-12):2019-21.
-
1979: Kelsen D P; Gee T S; Chaganti R S
Philadelphia chromosome positive chronic myelogenous leukemia developing in a patient with acute lymphoblastic leukemia.
Cancer 1979;43(5):1782-7.
-
1978: Kelsen D P; Cvitkovic E; Bains M; Shils M; Howard J; Hopfan S; Golbey R B
cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas.
Cancer treatment reports 1978;62(7):1041-6.
-
1978: Kelsen S G; Kelsen D P; Fleeger B F; Jones R C; Rodman T
Emergency room assessment and treatment of patients with acute asthma. Adequacy of the conventional approach.
The American journal of medicine 1978;64(4):622-8.
-
1977: Kelsen S G; McGuckin M; Kelsen D P; Cherniack N S
Airborne contamination of fine-particle nebulizers.
JAMA : the journal of the American Medical Association 1977;237(21):2311-4.
Sign-in to see more
